My HPRA: Register

LAMICTAL

200 Milligram Chewable/Dispersible tablet

GlaxoSmithKline (Ireland) LimitedPA1077/061/010

Main Information

Trade NameLAMICTAL
Active SubstancesLAMOTRIGINE
Strength200 Milligram
Dosage FormChewable/Dispersible tablet
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/061/010

Group Information

ATC CodeN03AX09 Other antiepileptics

Status

Authorised/WithdrawnAuthorised
Licence Issued05/11/2000
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may be renewed (B)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.